A new blood thinning drug could help more than one million people in the UK, potentially reducing the need for home care due to stroke.
Dabigatran etexilate, known as Pradaxa, was found to significantly reduce the risk of stroke in patients with heart rhythm disorder atrial fibrillation, it has been found.
The drug has been shown to be more effective than warfarin, which is widely used to treat the disorder.
Dr Peter Coleman, Deputy Director of Research at The Stroke Association, said: "The findings from this study provide a strong, positive backing for dabigatran etexilate which appears to be an easier treatment to manage and therefore has the potential to improve the quality of life for many people."
This comes after comments from professor Graham MacGregor, of the Blood Pressure Association, which said that people who do not like to get their blood pressure checked by a doctor should seek alternative options in order to stave off cardiovascular conditions such as stroke.